镇静催眠药合理使用专家意见

2021-04-30 中国精神科相关专家小组 中国药物滥用防治杂志.2021.27(2):103-105.

镇静催眠药(sedative and hypnotics)具有镇静催眠、抗焦虑、抗惊厥、抗癫痫及肌肉松弛作用,广泛应用于临床各科,是目前全球处方最多的药物品种之一。但临床医师在处方该类药物时也面临着各

中文标题:

镇静催眠药合理使用专家意见

发布日期:

2021-04-30

简要介绍:

镇静催眠药(sedative and hypnotics)具有镇静催眠、抗焦虑、抗惊厥、抗癫痫及肌肉松弛作用,广泛应用于临床各科,是目前全球处方最多的药物品种之一。但临床医师在处方该类药物时也面临着各种潜在的风险。本文试图阐述如何平衡镇静催眠药使用的利与弊,希望为临床医师合理、辩证使用镇静催眠药提供参考。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=镇静催眠药合理使用专家意见_江海峰.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1b96c1c00210a46a, title=镇静催眠药合理使用专家意见, enTitle=, guiderFrom=中国药物滥用防治杂志.2021.27(2):103-105., authorId=0, author=, summary=镇静催眠药(sedative and hypnotics)具有镇静催眠、抗焦虑、抗惊厥、抗癫痫及肌肉松弛作用,广泛应用于临床各科,是目前全球处方最多的药物品种之一。但临床医师在处方该类药物时也面临着各, cover=https://img.medsci.cn/2021522/1621697556314_2020535.jpg, journalId=0, articlesId=null, associationId=812, associationName=中国精神科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Fri Apr 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>镇静催眠药(sedative and hypnotics)具有镇静催眠、抗焦虑、抗惊厥、抗癫痫及肌肉松弛作用,广泛应用于临床各科,是目前全球处方最多的药物品种之一。但临床医师在处方该类药物时也面临着各种潜在的风险。本文试图阐述如何平衡镇静催眠药使用的利与弊,希望为临床医师合理、辩证使用镇静催眠药提供参考。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=112222, tagName=镇静催眠药)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=24938, guiderKeyword=镇静药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9538, appHits=323, showAppHits=0, pcHits=942, showPcHits=9215, likes=3, shares=23, comments=26, approvalStatus=1, publishedTime=Sat May 22 23:42:00 CST 2021, publishedTimeString=2021-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 22 23:32:45 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 23:34:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=镇静催眠药合理使用专家意见_江海峰.pdf)])
镇静催眠药合理使用专家意见_江海峰.pdf
下载请点击:
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207375, encodeId=b35f120e375c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:01:00 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202363, encodeId=1e51120236397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d086550657, createdName=ms8000001353465209, createdTime=Mon Mar 14 00:08:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182648, encodeId=1cab1182648b5, content=巳学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:38:05 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069013, encodeId=e78910690138b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:55:34 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016922, encodeId=48f0101692223, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Mon Sep 13 06:52:08 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2022-03-30 283488816

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207375, encodeId=b35f120e375c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:01:00 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202363, encodeId=1e51120236397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d086550657, createdName=ms8000001353465209, createdTime=Mon Mar 14 00:08:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182648, encodeId=1cab1182648b5, content=巳学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:38:05 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069013, encodeId=e78910690138b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:55:34 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016922, encodeId=48f0101692223, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Mon Sep 13 06:52:08 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2022-03-14 ms8000001353465209

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207375, encodeId=b35f120e375c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:01:00 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202363, encodeId=1e51120236397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d086550657, createdName=ms8000001353465209, createdTime=Mon Mar 14 00:08:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182648, encodeId=1cab1182648b5, content=巳学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:38:05 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069013, encodeId=e78910690138b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:55:34 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016922, encodeId=48f0101692223, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Mon Sep 13 06:52:08 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2022-01-09 ms6000000225486324

    巳学习,很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1207375, encodeId=b35f120e375c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:01:00 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202363, encodeId=1e51120236397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d086550657, createdName=ms8000001353465209, createdTime=Mon Mar 14 00:08:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182648, encodeId=1cab1182648b5, content=巳学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:38:05 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069013, encodeId=e78910690138b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:55:34 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016922, encodeId=48f0101692223, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Mon Sep 13 06:52:08 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2021-11-10 122b8c2dm25(暂无昵称)

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1207375, encodeId=b35f120e375c1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:01:00 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202363, encodeId=1e51120236397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d086550657, createdName=ms8000001353465209, createdTime=Mon Mar 14 00:08:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182648, encodeId=1cab1182648b5, content=巳学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:38:05 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069013, encodeId=e78910690138b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4abf2353958, createdName=122b8c2dm25(暂无昵称), createdTime=Wed Nov 10 16:55:34 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016922, encodeId=48f0101692223, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b345459375, createdName=ms9000001304183114, createdTime=Mon Sep 13 06:52:08 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2021-09-13 ms9000001304183114

    学习

    0